Since CDH1 and RHOA mutations often co-occur in diffuse-type GC, most studies have assumed that anoikis inhibition by an altered RhoA pathway enables discohesive gastric cells to develop into SRCC60,61. This evidence concerns the gene CDH1 and gastric cancer.